» Articles » PMID: 36145511

Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Sep 23
PMID 36145511
Authors
Affiliations
Soon will be listed here.
Abstract

The bidirectional pulsatile movement of cerebrospinal fluid (CSF), instead of the traditionally believed unidirectional and constant CSF circulation, has been demonstrated. In the present study, the structure and parameters of the CSF compartments were revisited in our comprehensive and validated central nervous system (CNS)-specific, physiologically based pharmacokinetic (PBPK) model of healthy rats (LeiCNS-PK3.0). The bidirectional and site-dependent CSF movement was incorporated into LeiCNS-PK3.0 to create the new LeiCNS-PK"3.1" model. The physiological CSF movement rates in healthy rats that are unavailable from the literature were estimated by fitting the PK data of sucrose, a CSF flow marker, after intra-CSF administration. The capability of LeiCNS-PK3.1 to describe the PK profiles of other molecules was compared with that of the original LeiCNS-PK3.0 model. LeiCNS-PK3.1 demonstrated superior description of the CSF PK profiles of a range of small molecules after intra-CSF administration over LeiCNS-PK3.0. LeiCNS-PK3.1 also retained the same level of predictability of CSF PK profiles in cisterna magna after intravenous administration. These results support the theory of bidirectional and site-dependent CSF movement across the entire CSF space over unidirectional and constant CSF circulation in healthy rats, pointing out the need to revisit the structures and parameters of CSF compartments in CNS-PBPK models.

Citing Articles

Epidural pressure measurement using a fiber-optic sensor (proof-of-principle in vivo animal trial).

Barz S, Friedemann M, Voigt S, Melloh M, Barz T Animal Model Exp Med. 2024; 7(5):769-776.

PMID: 38981680 PMC: 11528391. DOI: 10.1002/ame2.12469.


Mathematical modeling of transdermal delivery of topical drug formulations in a dynamic microfluidic diffusion chamber in health and disease.

Szederkenyi G, Kocsis D, Vaghy M, Czaran D, Sasvari P, Lengyel M PLoS One. 2024; 19(4):e0299501.

PMID: 38603673 PMC: 11008853. DOI: 10.1371/journal.pone.0299501.


Interspecies Brain PBPK Modeling Platform to Predict Passive Transport through the Blood-Brain Barrier and Assess Target Site Disposition.

Mehta P, Soliman A, Rodriguez-Vera L, Schmidt S, Muniz P, Rodriguez M Pharmaceutics. 2024; 16(2).

PMID: 38399280 PMC: 10892872. DOI: 10.3390/pharmaceutics16020226.


The relationship between myodural bridge, atrophy and hyperplasia of the suboccipital musculature, and cerebrospinal fluid dynamics.

Yang H, Wei X, Gong J, Du X, Feng H, Su C Sci Rep. 2023; 13(1):18882.

PMID: 37919345 PMC: 10622500. DOI: 10.1038/s41598-023-45820-x.


In Silico Pharmacology for Evidence-Based and Precision Medicine.

Spanakis M Pharmaceutics. 2023; 15(3).

PMID: 36986874 PMC: 10054111. DOI: 10.3390/pharmaceutics15031014.

References
1.
Cserr H . Potassium exchange between cerebrospinal fluid, plasma, and brain. Am J Physiol. 1965; 209(6):1219-26. DOI: 10.1152/ajplegacy.1965.209.6.1219. View

2.
Monine M, Norris D, Wang Y, Nestorov I . A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration. J Pharmacokinet Pharmacodyn. 2021; 48(5):639-654. DOI: 10.1007/s10928-021-09761-0. View

3.
Tangen K, Hsu Y, Zhu D, Linninger A . CNS wide simulation of flow resistance and drug transport due to spinal microanatomy. J Biomech. 2015; 48(10):2144-54. DOI: 10.1016/j.jbiomech.2015.02.018. View

4.
BOSCHI G, Sandouk P, Scherrmann J . Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability. Br J Pharmacol. 1999; 128(4):917-24. PMC: 1571713. DOI: 10.1038/sj.bjp.0702873. View

5.
de Lange E . Utility of CSF in translational neuroscience. J Pharmacokinet Pharmacodyn. 2013; 40(3):315-26. PMC: 3663203. DOI: 10.1007/s10928-013-9301-9. View